www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

   

New drug combo helps HIV patients with few options

(Reuters)
Updated: 2007-07-06 15:58

WASHINGTON - A combination of two experimental AIDS drugs can help control the deadly virus in people who are infected with highly resistant forms, an international team of researchers reported on Thursday.

The two drugs -- called etravirine, or TMC125, and darunavir, or TMC114 -- are both made by Tibotec Pharmaceuticals, Ltd., a division of Johnson & Johnson.

The trial of patients in 18 countries offers another weapon for people infected with drug-resistant forms of the AIDS virus -- about 10 percent of those not yet treated, the researchers report in the Lancet medical journal.

"This study is one of the most significant worldwide HIV/AIDS clinical trials in recent years," said Dr. William Towner, of Kaiser Permanente Southern California, who worked on the study. "It showed that when the two drugs are used in combination, there is a good chance HIV can be very effectively controlled in patients who have advanced, multi-drug resistant HIV."

TMC125 is in a class of HIV drugs called non-nucleoside reverse transcriptase inhibitors or NNRTIs. TMC114, which is now approved and sold under the brand name Prezista, is a protease inhibitor.

The drugs do not cure the infection but can control what is known as viral load -- how much virus is circulating in the body. Higher viral load usually means more symptoms.

Different classes of HIV drugs attack the virus at different stages in its cycle of infection and replication.

"Treating a resistant virus with two active agents has been a mantra in HIV care for quite some time," Towner said.

"Adding only one active agent to a patient experiencing drug failure usually results in the rapid, predictable development of resistance to that agent. Very seldom do patients get the chance to receive two potent new investigational agents in one clinical trial."

In the trials, known as DUET 1 and DUET 2, patients who got two drugs instead of one had better control of the human immunodeficency virus that causes AIDS. Close to 40 million people worldwide are infected with HIV.



Top Lifestyle News  
Today's Top News  
Most Commented/Read Stories in 48 Hours
主站蜘蛛池模板: 国产欧美一区二区成人影院 | 国产美女一区二区 | 欧美精品国产制服第一页 | 国产欧美久久精品 | 亚洲国产精品一区二区三区久久 | 国内自拍第100页 | 91一级片| 免费精品久久久久久中文字幕 | 久久国产精品久久久 | www.操操 | 婷婷色综合久久五月亚洲 | 男人的天堂欧美 | 日韩美女视频网站 | 男女男精品视频网站在线观看 | 美国毛片视频 | 欧美在线一区二区三区欧美 | 黄页美女 | 亚洲视频欧美 | 中文字幕一区视频一线 | 国产一级视频久久 | 国产一级精品高清一级毛片 | 91精品手机国产在线能 | 思99re久久这里只有精品首页 | 亚洲精品美女在线观看播放 | 亚欧精品一区二区三区 | 久久久久女人精品毛片九一 | 国产成人精品三级91在线影院 | 久久九九精品一区二区 | 香港国产特级一级毛片 | 国产成人丝袜网站在线看 | 成年人在线看片 | 超清国产粉嫩456在线免播放 | 在线观看日本永久免费视频 | 国产精品久久视频 | 欧美一区二区视频 | 日韩欧美一级毛片视频免费 | 免费国产成人高清在线观看不卡 | 特级一级毛片视频免费观看 | 日本一区二区三区欧美在线观看 | 香蕉香蕉国产片一级一级毛片 | 韩国美女高清爽快一级毛片 |